Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Can treated municipal wastewater be reused after ozonation and nanofiltration? Results from a pilot study of pharmaceutical removal in Henriksdal WWTP, Sweden.

Flyborg, Lena LU ; Björlenius, Berndt and Persson, Kenneth M LU (2010) In Water Science and Technology 61(5). p.1113-1120
Abstract
The objective of this study was to evaluate the potential of nanofiltration (NF) and ozonation for indirect potable reuse in terms of pharmaceutical residuals. To simultaneously obtain a reasonable retentate volume for further treatment, the tests were performed at a high volume reduction factor (VRF) of 60. The feed to the pilot plant was the effluent from a BNR plant with a final process step of chemical precipitation and rapid sand filtration. Two tests were performed 1) nanofiltration of treated wastewater followed by ozonation and 2) ozonated treated wastewater as feed to NF. Of the 95 pharmaceuticals analysed, three were not removed to the quantification limit, oxazepam in the first test and glibenclamide and ketoprofen in the... (More)
The objective of this study was to evaluate the potential of nanofiltration (NF) and ozonation for indirect potable reuse in terms of pharmaceutical residuals. To simultaneously obtain a reasonable retentate volume for further treatment, the tests were performed at a high volume reduction factor (VRF) of 60. The feed to the pilot plant was the effluent from a BNR plant with a final process step of chemical precipitation and rapid sand filtration. Two tests were performed 1) nanofiltration of treated wastewater followed by ozonation and 2) ozonated treated wastewater as feed to NF. Of the 95 pharmaceuticals analysed, three were not removed to the quantification limit, oxazepam in the first test and glibenclamide and ketoprofen in the second. The water quality after the two processes was similar, with an overall removal of pharmaceutical residuals of 99%. There are two advantages of ozonated water as feed to NF-a higher specific flux of 35% and a potential removal of ozonation by-products. The retention of some pharmaceuticals by NF was lower than anticipated, the major removal occurring in the ozonation. A tighter NF or RO is required in order to achieve higher pharmaceutical retention for further treatment of the retentate. (Less)
Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Water Science and Technology
volume
61
issue
5
pages
1113 - 1120
publisher
IWA Publishing
external identifiers
  • wos:000275653000005
  • pmid:20220232
  • scopus:77952472917
  • pmid:20220232
ISSN
0273-1223
DOI
10.2166/wst.2010.029
language
English
LU publication?
yes
id
2029ca6c-231b-4dda-8aa3-e7ca36a04e2d (old id 1582329)
date added to LUP
2016-04-01 13:04:46
date last changed
2022-03-29 05:28:39
@article{2029ca6c-231b-4dda-8aa3-e7ca36a04e2d,
  abstract     = {{The objective of this study was to evaluate the potential of nanofiltration (NF) and ozonation for indirect potable reuse in terms of pharmaceutical residuals. To simultaneously obtain a reasonable retentate volume for further treatment, the tests were performed at a high volume reduction factor (VRF) of 60. The feed to the pilot plant was the effluent from a BNR plant with a final process step of chemical precipitation and rapid sand filtration. Two tests were performed 1) nanofiltration of treated wastewater followed by ozonation and 2) ozonated treated wastewater as feed to NF. Of the 95 pharmaceuticals analysed, three were not removed to the quantification limit, oxazepam in the first test and glibenclamide and ketoprofen in the second. The water quality after the two processes was similar, with an overall removal of pharmaceutical residuals of 99%. There are two advantages of ozonated water as feed to NF-a higher specific flux of 35% and a potential removal of ozonation by-products. The retention of some pharmaceuticals by NF was lower than anticipated, the major removal occurring in the ozonation. A tighter NF or RO is required in order to achieve higher pharmaceutical retention for further treatment of the retentate.}},
  author       = {{Flyborg, Lena and Björlenius, Berndt and Persson, Kenneth M}},
  issn         = {{0273-1223}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{1113--1120}},
  publisher    = {{IWA Publishing}},
  series       = {{Water Science and Technology}},
  title        = {{Can treated municipal wastewater be reused after ozonation and nanofiltration? Results from a pilot study of pharmaceutical removal in Henriksdal WWTP, Sweden.}},
  url          = {{http://dx.doi.org/10.2166/wst.2010.029}},
  doi          = {{10.2166/wst.2010.029}},
  volume       = {{61}},
  year         = {{2010}},
}